ProfessorUniversity of Texas MD Anderson Cancer Center
Disclosure information not submitted.
Multimodal Imageable Eye90 microspheres® Radioembolization for Hepatocellular Carcinoma - 6 Month Interim Safety and Efficacy and 3 Month Liver Volume Results from a First in Human Trial
Monday, March 25, 20243:45 PM – 3:54 PM MT
Comparison of 3D Voxel-Based Yttrium-90 Dosimetry Quantification of using Y90 PET/CT Versus Y90 SPECT/CT
Wednesday, March 27, 20243:09 PM – 3:18 PM MT